Study design & results
Available in the Gosset platform where reported.
Trial intelligence / Profile preview
Phase III trial of 5-dose vial Sabin strain inactivated poliomyelitis vaccine (Vero cell) in infants, children, and adults
CTR20192430Phase 3Active
- Sponsor
- Sinovac Biotech Ltd.
- Start
- Nov 2020
- Modality
- Vaccines & Immunotherapeutics, Recombinant Proteins and Enzymes
- Countries
- 1
01
Overview
A Phase 3 trial of Sabin strain inactivated poliovirus vaccine in poliomyelitis, sponsored by Sinovac Biotech Ltd.. Started Nov 2020; status: active.
02
Drugs
Sabin strain inactivated poliovirus vaccine
03
Conditions
poliomyelitis
Beyond the preview
Go deeper on CTR20192430.
Study design, results and competitive context are available in the Gosset platform where reported.
Competitive context
Available in the Gosset platform where reported.
Bring the full picture into focus.
See how Gosset can support your research on CTR20192430.